Gadolinium is the contrast agent given before an MRI (magnetic resonance imaging) to increase the contrast of blood vessels during an MRI procedure so that the radiologist can better diagnose abnormalities. Unfortunately gadolinium is linked to a rare disease called nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD). This disease causes thickening or tightening of the skin and connective tissues, which severely limits a patient’s ability to move, and it also causes pain, muscle weakness, scarring of internal organs and difficulty bending joints.
Gadolinium is ordinarily quickly eliminated from the body by the kidneys. The problem occurs when the person undergoing the MRI has impaired kidney functions.
Potential lawsuits will be reviewed for any individuals who have experienced symptoms of the MRI skin disease, which could include:
– Burning, itching, swelling, hardening and tightening of the skin
– Red or dark patches on the skin
– Yellow spots on the whites of the eyes
– Stiff joints with trouble straightening or moving the limbs
– Pain in the hip bones or ribs
– Generalized muscle weakness
If you had an MRI and subsequently developed these symptoms and/or have since been diagnosed with NSF/NFD you may have a major claim for damages. Please contact Mike Miller of Solberg, Stewart & Miller for a free consultations.